title: Rubella in Poland in 2014
abstract: In 2004, Poland has adopted the WHO goal of rubella elimination and congenital rubella syndrome prevention. The main target of the Programme is to stop transmission of the virus in the environment and prevention of congenital rubella in children. In Poland participation in the rubella elimination program requires clinical diagnosis of rubella cases and their confirmation with laboratory tests. Vaccination against rubella was introduced in 1987, initially only in 13 - year-old girls. Since 2003, single jab vaccination against rubella, measles and mumps is used (MMR vaccine for all children: primary vaccination at the age 13-15 months and a booster vaccination at the age of 10).
  
  
  
  To assess epidemiological situation of rubella in Poland in 2014, including vaccination coverage in Polish
  population.
  
  
  
  The descriptive analysis was based on data retrieved from routine mandatory surveillance system and published in the annual bulletins “Infectious diseases and poisonings in Poland in 2014” and “Vaccinations in Poland in 2014” (MP. Czarkowski, Warszawa 2014, NIZP-PZH, GIS).
  
  
  
  In 2014, there was a significant decrease in the number of rubella cases - with registered 5891 cases (in 2013 - 38 548 cases) - and a decline in incidence (from 101.1 per 100 000 to 15.3). The highest incidence, regardless of gender and the environment was observed in the age group 5-6 years (respectively 93.8 and 109.4 per 100 000). Similarly to 2013, rubella incidence of males was higher than the incidence in girls and women (20.0 versus 10.9). In 2014, no cases of congenital rubella syndrome were registered.
  
  
  
  The proportion of laboratory tests confirming/excluding rubella infection is still very low in Poland. In 2014, only 0.6% of rubella cases were laboratory confirmed.
authors.affiliation: National Institute of Public Health-National Institute of Hygiene, Department of Epidemiology
authors.forename: Iwona
authors.initials: I
authors.lastname: Paradowska-Stankiewicz
authors.affiliation: The State Sanitary Inspection MSW in Warsaw
authors.forename: Justyna
authors.initials: J
authors.lastname: Rogalska
authors.affiliation: University of Tempere in Finland & National Institute of Public Health, National Institute of Hygiene in Warsaw, Doctoral Studies
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Polkowska
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D011044:Poland / Q000453:epidemiology; D012042:Registries; D012409:Rubella / Q000453:epidemiology* / Q000517:prevention & control; D012411:Rubella Vaccine / Q000627:therapeutic use*; D012424:Rural Population; D017678:Sex Distribution; D014505:Urban Population; D055815:Young Adult
chemical_list: D012411:Rubella Vaccine